Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below Two Hundred Day Moving Average of $0.75
Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below Two Hundred Day Moving Average of $0.75
Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Rating) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.75 and traded as low as $0.61. Northwest Biotherapeutics shares last traded at $0.64, with a volume of 7,043,841 shares changing hands.
Northwest Biotherapeutics, Inc.(OTCMKTS: NWBO — 获取评级)的股价在周二的交易中跌破了其200天移动平均线。该股的200天移动平均线为0.75美元,交易价格低至0.61美元。Northwest Biotherapeutics股票最后一次交易价格为0.64美元,成交量为7,043,841股易手。
Northwest Biotherapeutics Stock Performance
西北生物疗法股票表现
The stock has a market cap of $686.45 million, a price-to-earnings ratio of -6.35 and a beta of -0.03. The company has a 50-day moving average of $0.68 and a 200-day moving average of $0.75.
该股的市值为6.8645亿美元,市盈率为-6.35,beta值为-0.03。该公司的50天移动平均线为0.68美元,200天移动平均线为0.75美元。
About Northwest Biotherapeutics
关于西北生物疗法
(Get Rating)
(获取评分)
Northwest Biotherapeutics, Inc is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L.
Northwest Biotherapeutics, Inc是一家生物技术公司,从事癌症个性化免疫疗法的开发。它提供dcVax技术平台,该平台使用活化的树突状细胞来动员患者自身的免疫系统来攻击他们的癌症。该公司由Alton L创立.
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on Northwest Biotherapeutics (NWBO)
- On Holding AG Sprints Higher on Margin Expansion and Guidance
- Price Growth & Yield: For That Magical Combo, Leave the U.S.
- Game-Changing News For Tesla Investors
- DOW New Hghs Coming Sooner Than Later
- The Tide Is Turning For Harley-Davidson
- 免费获取 StockNews.com 关于西北生物疗法 (NWBO) 的研究报告
- On Holding AG 在利润率扩张和指导下冲刺走高
- 价格增长和收益率:对于那个神奇的组合,离开美国
- 对于特斯拉投资者来说,改变游戏规则的新闻
- 道琼斯指数新高迟早会到来
- 哈雷戴维森的潮流正在转向
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接收《西北生物疗法日报》的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Northwest Biotherapeutics及相关公司的最新新闻和分析师评级的简明每日摘要。